News & Updates

Stem cell–like epigenetic signature predicts resistance to CD19 CAR T-cell therapy in ALL

17 May 2022 by

A stem cell–like epigenetic signature is identified in pretreatment samples from young patients with acute lymphoblastic leukaemia (ALL) who are resistant to CD19 chimeric antigen receptor (CAR) T-cell therapy, with potential utility for refining patient selection for appropriate treatment.

Stem cell–like epigenetic signature predicts resistance to CD19 CAR T-cell therapy in ALL

17 May 2022

Working out can protect cancer survivors against COVID-19

16 May 2022

For patients with a history of cancer, exercising appears to lower the risk of contracting COVID-19 infection, according to a study.

Working out can protect cancer survivors against COVID-19

16 May 2022

AI predicts effectiveness of lung cancer immunotherapy

16 May 2022 by

An artificial intelligence (AI)–powered spatial analytical tool for predicting the effectiveness of immune checkpoint inhibitors (ICIs) in advanced non-small-cell lung cancer (NSCLC) has been developed by researchers from the Chinese University of Hong Kong (CUHK), Seoul National University, Sungkyunkwan University, Ajou University, and AI start-up Lunit.

AI predicts effectiveness of lung cancer immunotherapy

16 May 2022

Fruits, freshwater fish may be protective against breast cancer in Asians

14 May 2022

Women who consume high amounts of fruit and freshwater fish appear to have a lower risk of developing breast cancer, according to a Vietnamese cohort study.

Fruits, freshwater fish may be protective against breast cancer in Asians

14 May 2022

SBRT yields positive responses in patients with spinal metastases

14 May 2022

Treatment with stereotactic body radiotherapy (SBRT) results in encouraging palliative responses, with >80 percent of patients having initial pain responses and 60 percent durable pain responses, according to a recent study. Dose escalation can help improve initial complete response (CR) rates.

SBRT yields positive responses in patients with spinal metastases

14 May 2022

Chamomile improves skin recovery in breast cancer patients with radiodermatitis

13 May 2022

A topical formulation containing chitosan-coated Chamomilla recutita (L.) rauschert microparticles does not lower any grade of radiodermatitis (RD) but is effective in reducing grade ≥2 toxicity to improve skin recovery and diminish high-intensity local symptoms in women with breast cancer, a study has shown.

Chamomile improves skin recovery in breast cancer patients with radiodermatitis

13 May 2022

MRI provides long-term prognosis of patients with biochemical recurrence

13 May 2022

Use of prostatectomy bed magnetic resonance imaging (MRI) can give out long-term prognostic information for assessing patients with biochemical recurrence following prostatectomy, reveals a recent study.

MRI provides long-term prognosis of patients with biochemical recurrence

13 May 2022

Smokers at higher risk of death from prostate cancer

13 May 2022

Prostate cancer patients who are also smokers have a greater risk of death, an effect that is further exacerbated by obesity, reports a recent study.

Smokers at higher risk of death from prostate cancer

13 May 2022

Sotorasib continues to impress at 2 years in KRAS G12C–mutant NSCLC

13 May 2022 by

Long-term findings from the pooled phase I/II CodeBreak 100 trial support the efficacy of sotorasib in certain patients with KRAS G12C–mutant non–small cell lung cancer (NSCLC).

Sotorasib continues to impress at 2 years in KRAS G12C–mutant NSCLC

13 May 2022

Neoadjuvant nivolumab plus chemo: New SoC in resectable NSCLC

13 May 2022 by

In patients with resectable non-small-cell lung cancer (NSCLC), neoadjuvant nivolumab in combination with platinum-based chemotherapy significantly improves event-free survival (EFS) and shows a trend towards better overall survival (OS) vs chemotherapy alone, without impeding the feasibility of surgery or increasing adverse events (AEs), according to results of the phase III CheckMate 816 trial.

Neoadjuvant nivolumab plus chemo: New SoC in resectable NSCLC

13 May 2022

News & Updates

Filter by Specialty:

Specialty:

Stem cell–like epigenetic signature predicts resistance to CD19 CAR T-cell therapy in ALL

Stem cell–like epigenetic signature predicts resistance to CD19 CAR T-cell therapy in ALL

Working out can protect cancer survivors against COVID-19

Working out can protect cancer survivors against COVID-19

AI predicts effectiveness of lung cancer immunotherapy

AI predicts effectiveness of lung cancer immunotherapy

Fruits, freshwater fish may be protective against breast cancer in Asians

Fruits, freshwater fish may be protective against breast cancer in Asians

SBRT yields positive responses in patients with spinal metastases

SBRT yields positive responses in patients with spinal metastases

Chamomile improves skin recovery in breast cancer patients with radiodermatitis

Chamomile improves skin recovery in breast cancer patients with radiodermatitis

MRI provides long-term prognosis of patients with biochemical recurrence

MRI provides long-term prognosis of patients with biochemical recurrence

Smokers at higher risk of death from prostate cancer

Smokers at higher risk of death from prostate cancer

Sotorasib continues to impress at 2 years in KRAS G12C–mutant NSCLC

Sotorasib continues to impress at 2 years in KRAS G12C–mutant NSCLC

Neoadjuvant nivolumab plus chemo: New SoC in resectable NSCLC

Neoadjuvant nivolumab plus chemo: New SoC in resectable NSCLC